Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin versus glimepiride in type 2 diabetes (CAROLINA)
*Correspondence: Jiteng Wang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Semaglutide should not be used during pregnancy, and effective birth control is often recommended while on therapy and for a period after stopping, based on product labeling and clinical guidance
The reason is entirely about gastrointestinal tolerability nausea, diarrhea, and vomiting were clearly dose-dependent and concentrated in the weeks right after each step-up
They state that the GLP-1 market is at an inflection point, mostly because of the launch of oral therapies and the expansion of Medicare access in the U.S
A., Agricola, E., and Palazzuoli, V